Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic potential of p53 reactivation in cervical cancer
Xiangxuan Zhao, Wei Sun, Ying Ren, et al.
Critical Reviews in Oncology/Hematology (2020) Vol. 157, pp. 103182-103182
Closed Access | Times Cited: 23

Showing 23 citing articles:

Cancer and HIV: The Molecular Mechanisms of the Deadly Duo
Aadilah Omar, N M Marques, Nicole Crawford
Cancers (2024) Vol. 16, Iss. 3, pp. 546-546
Open Access | Times Cited: 6
DNA methyltransferase DNMT3A inhibits TP53AIP1 expression and promotes cervical cancer development and metastasis
Xiaohong Pan, Xiuluan Du, Shenshan Jia
Cytotechnology (2025) Vol. 77, Iss. 2
Closed Access
Xanthorrhizol, a potential anticancer agent, from Curcuma xanthorrhiza Roxb
Adelina Simamora, Kris Herawan Timotius, Mükerrem Betül Yerer, et al.
Phytomedicine (2022) Vol. 105, pp. 154359-154359
Closed Access | Times Cited: 19
Aconiti Lateralis Radix Praeparata as Potential Anticancer Herb: Bioactive Compounds and Molecular Mechanisms
Wen Zhang, Chaoying Lu, Shuhui Cai, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 18
siRNA-E6 sensitizes HPV-16-related cervical cancer through Oxaliplatin: an in vitro study on anti-cancer combination therapy
Parisa Shiri Aghbash, Nima Hemmat, Behzad Baradaran, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 11
Post-Translational Modifications of p53 in Ferroptosis: Novel Pharmacological Targets for Cancer Therapy
Le Zhang, Ningning Hou, Bing Chen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14
Hyperactivating p53 in Human Papillomavirus-Driven Cancers: A Potential Therapeutic Intervention
Yusuf M. Idres, Nigel A.J. McMillan, Adi Idris
Molecular Diagnosis & Therapy (2022) Vol. 26, Iss. 3, pp. 301-308
Open Access | Times Cited: 13
Co-Delivery of p53 Restored and E7 Targeted Nucleic Acids by Poly (Beta-Amino Ester) Complex Nanoparticles for the Treatment of HPV Related Cervical Lesions
Jinfeng Xiong, Guannan Li, Xinyu Mei, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
LncRNA CARMN inhibits cervical cancer cell growth via the miR-92a-3p/BTG2/Wnt/β-catenin axis
Lijun Wang, Hu Zhao, Ying Fang, et al.
Physiological Genomics (2022) Vol. 55, Iss. 1, pp. 1-15
Closed Access | Times Cited: 10
Fenbendazole and its synthetic analog interfere with HeLa cells’ proliferation and energy metabolism via inducing oxidative stress and modulating MEK3/6-p38-MAPK pathway
Yi Peng, Jie Pan, Fengting Ou, et al.
Chemico-Biological Interactions (2022) Vol. 361, pp. 109983-109983
Open Access | Times Cited: 9
Potential Therapeutic Targets for the Treatment of HPV-Associated Malignancies
Ziyao Lu, Shahab Haghollahi, Muhammad Zubair Afzal
Cancers (2024) Vol. 16, Iss. 20, pp. 3474-3474
Open Access | Times Cited: 1
Targeting ESM1/ VEGFα signaling axis: a promising therapeutic avenue for angiogenesis in cervical squamous cell carcinoma
Dan Li, Lei Su, Shen Xue, et al.
Journal of Cancer (2023) Vol. 14, Iss. 10, pp. 1725-1735
Open Access | Times Cited: 4
Next generation sequencing uncovers multiple miRNAs associated molecular targets in gallbladder cancer patients
Rahul Saxena, Baskar Chakrapani, M. P. Sarath Krishnan, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Raspberry Extract With Potential Antitumor Activity Against Cervical Cancer
NELSON SHAM, Chenglu Qin, Ziwen Zhu, et al.
Anticancer Research (2021) Vol. 41, Iss. 7, pp. 3343-3348
Open Access | Times Cited: 10
Targeted Therapy as a Potential De-Escalation Strategy in Locally Advanced HPV-Associated Oropharyngeal Cancer: A Literature Review
Lennox Chitsike, Penelope J. Duerksen-Hughes
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 8
Caffeic Acid Phenethyl Ester Inhibits Ubiquitination and Degradation of p53 and Blocks Cervical Cancer Cell Growth
Wei Li, Yang Cong, Zhongxiu Shi, et al.
Current Molecular Medicine (2022) Vol. 23, Iss. 9, pp. 960-970
Closed Access | Times Cited: 5
Comparative efficacy and safety of extended adjuvant endocrine therapy for hormone receptor-positive early breast cancer: a Bayesian network meta-analysis
Peng He, Jing Li, Minyan Chen, et al.
Breast Cancer Research and Treatment (2023)
Closed Access | Times Cited: 1
Anti-cervical cancer mechanism of bioactive compounds from Alangium platanifolium based on the ‘compound-target-disease’ network
Hao Zhang, Ruiming Zhang, Yuefen Su, et al.
Heliyon (2023) Vol. 9, Iss. 10, pp. e20747-e20747
Open Access | Times Cited: 1
Recombinant Human Adenovirus-p53 Therapy for the Treatment of Cervical Cancer: A Meta-Analysis
Yaru Guo, Jiuzhou Chen, Xiwen Zhang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 3
Value of serum p53, PKD1, and MAP2K4 in evaluating the condition and prognosis of endometrial carcinoma.
Xiang Zhang, Yue Huang, Xuecheng Pang
PubMed (2022) Vol. 14, Iss. 7, pp. 5059-5067
Closed Access | Times Cited: 1
ESM1/VEGFα/ERK signaling axis augments cell proliferation and tumor angiogenesis in human cervical squamous cell carcinoma
Yugang Huang, Dan Li, Yao Li, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Knockdown of PRKD2 Enhances Chemotherapy Sensitivity in Cervical Cancer via the TP53/CDKN1A Pathway
Zheng Hu, Ji Ma, Danni Gong, et al.
Current Cancer Drug Targets (2022) Vol. 23, Iss. 2, pp. 159-170
Closed Access
ESM1/VEGFα signaling pathway augments endothelial cell proliferation and tumor angiogenesis in human cervical squamous cell carcinoma
Yugang Huang, Dan Li, Yao Li, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top